These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7087684)

  • 21. The influence of oral contraceptive steroids on serum lipids.
    De Alvarez RR; Jahed FM; Spitalny KJ; Elkin H; Jaunakais I
    Am J Obstet Gynecol; 1973 Jul; 116(5):727-49. PubMed ID: 4351501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects, on the endometrium, of a new oral contraceptive: Physiostat].
    Delacroix P
    Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of a low-dose oral contraceptive (0,75 mg lynestrenol + 37,5 mug ethinyl estradiol) on ovarian function].
    Dericks-Tan JS; Schneider K; Taubert HD
    Arch Gynecol; 1979 Jul; 228(1-4):570. PubMed ID: 485478
    [No Abstract]   [Full Text] [Related]  

  • 24. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipid studies in women using combination type of oral contraceptives.
    Vaidya R; Purandare VN; Nain S; Gupta K; Rajwade N; Sheth UK
    J Obstet Gynaecol India; 1979 Jun; 29(3):644-6. PubMed ID: 12335922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
    Mink IB; Courey NG; Niswander KR; Moore RH; Lillie MA; Ambrus JL
    Am J Obstet Gynecol; 1974 Jun; 119(3):401-5. PubMed ID: 4275088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol".
    Farbiszewski R; Kurowska T
    Thromb Diath Haemorrh; 1970 Oct; 24(1):304-7. PubMed ID: 5483970
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of sex and dietary fats on platelet lipid biosynthesis in rat.
    Davenas E; Ciavatti M; Michel G; Renaud S
    Biochim Biophys Acta; 1983 Mar; 750(3):526-32. PubMed ID: 6824724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin E prevents the platelet abnormalities induced by estrogen in rat.
    Ciavatti M; Davenas E; Blache D; Renaud S
    Contraception; 1984 Sep; 30(3):279-87. PubMed ID: 6509982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic influence of oral contraceptives.
    Anberg A
    Acta Obstet Gynecol Scand; 1966; 45(S9):40. PubMed ID: 5958395
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
    Leis D; Botterman P; Ermler R; Maurer U
    Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
    Notelovitz M; Feldman EB; Gillespy M; Gudat J
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary results of comparative trials of oral contraceptives].
    Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
    Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in laboratory tests after treatment with a new contraceptive agent].
    Cervantes LF; López Barcena J; Calderón Márquez JJ
    Ginecol Obstet Mex; 1978 Apr; 43(258):285-97. PubMed ID: 80349
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
    Mandal B; Maity CR
    Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood pressure in women taking oral contraceptives.
    Weir RJ; Briggs E; Mack A; Naismith L; Taylor L; Wilson E
    Br Med J; 1974 Mar; 1(5907):533-5. PubMed ID: 4817186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.